全文获取类型
收费全文 | 21217篇 |
免费 | 1231篇 |
国内免费 | 661篇 |
专业分类
耳鼻咽喉 | 172篇 |
儿科学 | 571篇 |
妇产科学 | 287篇 |
基础医学 | 1838篇 |
口腔科学 | 169篇 |
临床医学 | 1859篇 |
内科学 | 5317篇 |
皮肤病学 | 175篇 |
神经病学 | 2726篇 |
特种医学 | 387篇 |
外科学 | 852篇 |
综合类 | 3105篇 |
一般理论 | 3篇 |
预防医学 | 2484篇 |
眼科学 | 331篇 |
药学 | 1324篇 |
5篇 | |
中国医学 | 1223篇 |
肿瘤学 | 281篇 |
出版年
2023年 | 406篇 |
2022年 | 883篇 |
2021年 | 1141篇 |
2020年 | 1212篇 |
2019年 | 857篇 |
2018年 | 810篇 |
2017年 | 785篇 |
2016年 | 782篇 |
2015年 | 785篇 |
2014年 | 1718篇 |
2013年 | 1842篇 |
2012年 | 1365篇 |
2011年 | 1418篇 |
2010年 | 1234篇 |
2009年 | 1069篇 |
2008年 | 962篇 |
2007年 | 811篇 |
2006年 | 678篇 |
2005年 | 575篇 |
2004年 | 490篇 |
2003年 | 520篇 |
2002年 | 395篇 |
2001年 | 327篇 |
2000年 | 219篇 |
1999年 | 177篇 |
1998年 | 142篇 |
1997年 | 152篇 |
1996年 | 128篇 |
1995年 | 93篇 |
1994年 | 98篇 |
1993年 | 62篇 |
1992年 | 64篇 |
1991年 | 74篇 |
1990年 | 47篇 |
1989年 | 39篇 |
1988年 | 35篇 |
1987年 | 47篇 |
1986年 | 30篇 |
1985年 | 71篇 |
1984年 | 70篇 |
1983年 | 47篇 |
1982年 | 43篇 |
1981年 | 45篇 |
1980年 | 61篇 |
1979年 | 49篇 |
1978年 | 32篇 |
1976年 | 28篇 |
1973年 | 34篇 |
1972年 | 26篇 |
1971年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的分析某儿童专科医院住院患儿年龄、性别分布、各系统疾病谱顺位及其各年龄段变化趋势,为医院临床研究及疾病预防提供依据。方法回顾性分析2010年1月1日-2019年12月31日收治的743517例患儿病例资料,按年度、年龄段、性别对疾病构成进行χ2检验及构成比分析。结果住院患儿男性多于女性,男女性别比为1.99:1;2015年-2019年收治的患儿人数较2010年-2014年增长16.71%;2010年-2019年收治的住院患儿疾病谱首位为呼吸系统疾病(28%),2015年-2019年内分泌、营养和代谢疾病的疾病构成比较2010年-2014年明显增加(P<0.001);各年龄段疾病谱顺位不同;女童内分泌、营养和代谢疾病的发生率高于男童(P<0.001)。结论呼吸系统疾病仍为儿童常见病、多发病,在提高对呼吸系统疾病诊疗水平的同时,应加强对内分泌、营养和代谢疾病的防治。 相似文献
2.
认知障碍是指记忆、语言、理解和判断等一个或多个方面的功能障碍,包括轻度认知障碍和各种类型的痴呆症。痴呆症是认知障碍最严重的表现,是一种导致患者日常生活、社会交往和工作能力发生显著变化的综合征。阿尔茨海默病(AD)是最常见的痴呆症类型,其次是血管性痴呆(VD)和其他神经退行性痴呆[1]。已知年龄与认知功能的退化密切相关。 相似文献
3.
目的研究免疫学检验联合检测诊断类风湿关节炎(RA)的临床价值。方法40例进行体检的健康人员作为参照组,同期40例类风湿关节炎患者作为研究组。两组受检者均接受免疫学检验联合检测,分析检验结果。比较两组类风湿因子(RF)、抗环瓜氨酸多肽抗体(抗CCP)、抗角蛋白抗体(AKA)阳性检出率,免疫球蛋白G(IgG)、补体C3、补体C4水平。结果研究组的RF、抗CCP、AKA阳性检出率分别为85.00%、62.50%、85.00%,均高于参照组的2.50%、5.00%、0,差异具有统计学意义(P<0.05)。研究组的IgG为(15.64±4.71)g/L、补体C3为(0.68±0.25)g/L、补体C4为(0.14±0.05)g/L,参照组的IgG为(10.47±3.08)g/L、补体C3为(1.23±0.31)g/L、补体C4为(0.29±0.17)g/L。研究组的IgG高于参照组,补体C3、补体C4低于参照组,差异具有统计学意义(P<0.05)。结论采用免疫学检验联合检测诊断类风湿关节炎的准确率较高,临床可以将其作为类风湿关节炎诊断的有效方案,为患者的疾病治疗提供参考。 相似文献
4.
《Research in social & administrative pharmacy》2022,18(9):3694-3698
In this paper, we argue that understanding and addressing the problem of poor-quality medical products requires a more interdisciplinary approach than has been evident to date. While prospective studies based on rigorous standardized methodologies are the gold standard for measuring the prevalence of poor-quality medical products and understanding their distribution nationally and internationally, they should be complemented by social science research to unpack the complex set of social, economic, and governance factors that underlie these patterns. In the following sections, we discuss specific examples of prospective quality surveys and of social science studies, highlighting the value of cross-sector partnerships in driving high-quality, policy-relevant research in this area. 相似文献
5.
《Journal of the American Medical Directors Association》2022,23(3):379-386.e3
ObjectivesPreclinical and clinical studies indicate a role for MLC901 (NeuroAiD II) in Alzheimer's disease (AD). The primary aim was to investigate its safety as add-on therapy to standard treatment and the secondary aims its effect on cognition and slowing disease progression.DesignRandomized double-blind placebo-controlled delayed-start study.Setting and ParticipantPatients with mild to moderate probable AD by NINCDS-ADRDA criteria, stable on acetylcholinesterase inhibitors or memantine (n = 125), were randomized to receive MLC901 (early starters) or placebo (delayed starters) for 6 months, followed by a further 6 months when all patients received MLC901, in a delayed-start design (clinical trial registration: ClinicalTrials.gov, NCT03038035).MethodsThe primary outcome measure was occurrence of serious adverse events (SAEs) at 6 months. Secondary outcomes included the Alzheimer's Disease Assessment Scale–Cognitive subscale (ADAS-Cog) and other assessment scales.ResultsThere was no significant difference in the risk of SAEs between early and delayed starters at month (M) 6 (22.6% vs 27.0%, risk difference ?4.4%, 90% CI –16.9% to 8.3%). Similarly, there was no significant difference in the risk of adverse events and the occurrence of stroke or vascular events between early and delayed starters throughout the 12-month study period. Early starters did not differ significantly on ADAS-Cog from delayed starters at M6 [mean difference (MD) ?1.0, 95% CI –3.3 to 1.3] and M12 (MD –2.35, 95% CI –5.45 to 0.74) on intention-to-treat analysis. Other cognitive assessment scales did not show significant differences.Conclusions and ImplicationsThis study of 125 persons with dementia found no evidence of a significant increase in adverse events between MLC901 and placebo, thus providing support for further studies on both efficacy and safety. Analyses suggest the potential of MLC901 in slowing down AD progression, but this requires further confirmation in larger and longer studies using biomarkers for AD. 相似文献
6.
目的 了解稳定期慢性阻塞性肺疾病 (chronic obstructive pulmonary disease,COPD) 患者报告结局现状,分析其影响因素及与炎症指标的相关性,为开展以患者为中心的早期护理干预提供依据。 方法 采用便利抽样法,选取2020年10月—2021年7月于南宁市某三级甲等医院呼吸内科门诊就诊的稳定期COPD患者作为调查对象,采用一般资料调查表、COPD患者报告结局量表修订版 (the Modified Patient-Reported Outcome Scale for COPD,mCOPD-PRO) 进行调查,并收集患者就诊时炎症指标的结果。采用多元线性回归分析稳定期COPD患者报告结局的影响因素,采用相关性分析探讨患者报告结局与炎症指标的关系。结果 该研究共纳入204例稳定期COPD患者,mCOPD-PRO得分为 (1.75±0.58) 分。多元线性回归分析显示,性别、合并疾病数量、病程、肺功能分级是稳定期COPD患者报告结局的影响因素 (P<0.05),可解释稳定期COPD患者报告结局10.8%的总变异。相关性分析显示,白细胞计数、中性粒细胞计数、嗜酸性粒细胞计数与稳定期COPD患者的mCOPD-PRO得分呈正相关 (P<0.05) ;总白蛋白浓度与其呈负相关 (P<0.05) 。结论 稳定期COPD患者报告结局有待改善,女性、合并疾病数量>3种、病程较长、肺功能分级较高的COPD患者报告的结局较差。COPD患者报告结局与白细胞计数、中性粒细胞计数、嗜酸性粒细胞计数、总白蛋白浓度相关。护理人员应关注稳定期COPD患者报告结局及炎症指标,在早期采取针对性的干预措施,以改善患者的生活质量。 相似文献
7.
《Mayo Clinic proceedings. Mayo Clinic》2022,97(7):1237-1246
ObjectiveTo determine the long-term cardiovascular disease risk of astronauts with spaceflight exposure compared with a well-matched cohort.MethodsNational Aeronautics and Space Administration (NASA) astronauts are selected into their profession based upon education, unique skills, and health and are exposed to cardiovascular disease risk factors during spaceflight. The Cooper Center Longitudinal Study (CCLS) is a generally healthy cohort from a preventive medicine clinic in Dallas, Texas. Using a matched cohort design, astronauts who were selected beginning April 1, 1959, (and each subsequent selection class through 2009) and exposed to spaceflight were matched to CCLS participants who met astronaut selection criteria; 1514 CCLS participants matched to 303 astronauts in a 5-to-1 ratio on sex, date of birth, and age. The outcome of cardiovascular mortality through December 31, 2016, was determined by death certificate or National Death Index.ResultsThere were 11 deaths caused by cardiovascular disease (CVD) among astronauts and 46 among CCLS participants. There was no evidence of increased mortality risk in astronauts (hazard ratio [HR]=1.10; 95% confidence interval [CI], 0.50 to 2.45) with adjustment for baseline cardiovascular covariates. However, the secondary outcome of CVD events showed an increased adjusted risk in astronauts (HR=2.41; 95% CI, 1.26 to 4.63).ConclusionNo increased risk of CVD mortality was observed in astronauts with spaceflight exposure compared with a well-matched cohort, but there was evidence of increased total CVD events. Given that the duration of spaceflight will increase, particularly on missions to Mars, continued surveillance and mitigation of CVD risk is needed to ensure the safety of those who venture into space. 相似文献
8.
《Journal of pediatric surgery》2023,58(5):856-861
Background/PurposeA small number of Hirschsprung disease (HD) patients develop inflammatory bowel disease (IBD)-like symptoms after pullthrough surgery. The etiology and pathophysiology of Hirschsprung-associated IBD (HD-IBD) remains unknown. This study aims to further characterize HD-IBD, to identify potential risk factors and to evaluate response to treatment in a large group of patients.MethodsRetrospective study of patients diagnosed with IBD after pullthrough surgery between 2000 and 2021 at 17 institutions. Data regarding clinical presentation and course of HD and IBD were reviewed. Effectiveness of medical therapy for IBD was recorded using a Likert scale.ResultsThere were 55 patients (78% male). 50% (n = 28) had long segment disease. Hirschsprung-associated enterocolitis (HAEC) was reported in 68% (n = 36). Ten patients (18%) had Trisomy 21. IBD was diagnosed after age 5 in 63% (n = 34). IBD presentation consisted of colonic or small bowel inflammation resembling IBD in 69% (n = 38), unexplained or persistent fistula in 18% (n = 10) and unexplained HAEC >5 years old or unresponsive to standard treatment in 13% (n = 7). Biological agents were the most effective (80%) medications. A third of patients required a surgical procedure for IBD.ConclusionMore than half of the patients were diagnosed with HD-IBD after 5 years old. Long segment disease, HAEC after pull through operation and trisomy 21 may represent risk factors for this condition. Investigation for possible IBD should be considered in children with unexplained fistulae, HAEC beyond the age of 5 or unresponsive to standard therapy, and symptoms suggestive of IBD. Biological agents were the most effective medical treatment.Level of EvidenceLevel 4 相似文献
9.
10.
目的探讨基于Heider平衡理论的健康教育在肝癌根治术患者中的应用效果。方法采用便利抽样法,于2019年7月—2020年10月选取在山西医科大学第一医院行根治手术治疗的肝癌患者为研究对象。按照随机数字表将患者分为观察组(n=51)和对照组(n=52)。对照组给予常规护理,观察组在对照组基础上给予基于Heider平衡理论的健康教育。采用压力感知量表(PSS)、抑郁-焦虑-压力自评量表(DASS)、Mishel疾病不确定感量表评估干预的效果。结果干预2个月后观察患者PSS、DASS评分均低于对照组,差异有统计学意义(P<0.01)。干预2个月后观察组患者Mishel疾病不确定感量表总分及各维度评分均低于对照组,差异有统计学意义(P<0.01)。结论基于Heider平衡理论的健康教育可降低患者感知压力,改善患者疾病不确定感,值得临床推广应用。 相似文献